ResearcherHumanitas UniversityActive in the last 2 years
Gioacchino Natoli
Matched on ORCID iD 0000-0003-0711-2411; OpenAlex author ID A5076459388. Sources: OpenAlex.
Their work
- Papers
- 10 (first author 2, last author 7)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 11
2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 2 papers
Papers 10
- A framework to mine laser microdissection-based omics data and uncover regulators of pancreatic cancer heterogeneity. Co-author DOI 10.1093/gigascience/giaf101↗
- Leveraging the tug-of-war with genomic retroelements to enhance immunotherapy of pancreatic cancer. First author DOI 10.1136/gutjnl-2024-333702↗
- Mapping functional to morphological variation reveals the basis of regional extracellular matrix subversion and nerve invasion in pancreatic cancer. Last author DOI 10.1016/j.ccell.2024.02.017↗
- Activation of endogenous retroviruses and induction of viral mimicry by MEK1/2 inhibition in pancreatic cancer. Last author DOI 10.1126/sciadv.adk5386↗
- Interferon regulatory factor 1 (IRF1) controls the metabolic programmes of low-grade pancreatic cancer cells. Last author DOI 10.1136/gutjnl-2021-325811↗
- Transcription factors as drivers of distinct pancreatic ductal adenocarcinoma (PDAC) programmes: a role for HNF4A. First author DOI 10.1136/gutjnl-2020-322814↗
- Tumor cell heterogeneity and its transcriptional bases in pancreatic cancer: a tale of two cell types and their many variants. Last author DOI 10.15252/embj.2020107206↗
- Pancreatic Cancer Cells Require the Transcription Factor MYRF to Maintain ER Homeostasis. Last author DOI 10.1016/j.devcel.2020.09.011↗
- FOXA2 controls the cis-regulatory networks of pancreatic cancer cells in a differentiation grade-specific manner. Last author DOI 10.15252/embj.2019102161↗
- Dissection of transcriptional and cis-regulatory control of differentiation in human pancreatic cancer. Last author DOI 10.15252/embj.201592404↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Giuseppe Riccardo Diaferia · 9 shared papers, 2016–2025 · strength 1.63
- Paper A framework to mine laser microdissection-based omics data and uncover regulators of pancreatic cancer heterogeneity. DOI 10.1093/gigascience/giaf101↗
- Paper Transcription factors as drivers of distinct pancreatic ductal adenocarcinoma (PDAC) programmes: a role for HNF4A. DOI 10.1136/gutjnl-2020-322814↗
- Paper Tumor cell heterogeneity and its transcriptional bases in pancreatic cancer: a tale of two cell types and their many va… DOI 10.15252/embj.2020107206↗
- Pierluigi Di Chiaro · 4 shared papers, 2023–2025 · strength 0.86
- Paper A framework to mine laser microdissection-based omics data and uncover regulators of pancreatic cancer heterogeneity. DOI 10.1093/gigascience/giaf101↗
- Paper Interferon regulatory factor 1 (IRF1) controls the metabolic programmes of low-grade pancreatic cancer cells. DOI 10.1136/gutjnl-2021-325811↗
- Paper Mapping functional to morphological variation reveals the basis of regional extracellular matrix subversion and nerve i… DOI 10.1016/j.ccell.2024.02.017↗
- Alessandro Zerbi · 5 shared papers, 2016–2024 · strength 0.61
- Paper Interferon regulatory factor 1 (IRF1) controls the metabolic programmes of low-grade pancreatic cancer cells. DOI 10.1136/gutjnl-2021-325811↗
- Paper Mapping functional to morphological variation reveals the basis of regional extracellular matrix subversion and nerve i… DOI 10.1016/j.ccell.2024.02.017↗
- Paper Pancreatic Cancer Cells Require the Transcription Factor MYRF to Maintain ER Homeostasis. DOI 10.1016/j.devcel.2020.09.011↗
- Marta Milan · 4 shared papers, 2019–2023 · strength 0.59
- Paper Tumor cell heterogeneity and its transcriptional bases in pancreatic cancer: a tale of two cell types and their many va… DOI 10.15252/embj.2020107206↗
- Paper Interferon regulatory factor 1 (IRF1) controls the metabolic programmes of low-grade pancreatic cancer cells. DOI 10.1136/gutjnl-2021-325811↗
- Paper Pancreatic Cancer Cells Require the Transcription Factor MYRF to Maintain ER Homeostasis. DOI 10.1016/j.devcel.2020.09.011↗
- Elisa Espinet · 1 shared paper, 2025 · strength 0.54
- Iros Barozzi · 2 shared papers, 2024–2025 · strength 0.53
- Paper A framework to mine laser microdissection-based omics data and uncover regulators of pancreatic cancer heterogeneity. DOI 10.1093/gigascience/giaf101↗
- Paper Mapping functional to morphological variation reveals the basis of regional extracellular matrix subversion and nerve i… DOI 10.1016/j.ccell.2024.02.017↗
- Gabriele Alfarano · 3 shared papers, 2019–2023 · strength 0.37
- Paper Interferon regulatory factor 1 (IRF1) controls the metabolic programmes of low-grade pancreatic cancer cells. DOI 10.1136/gutjnl-2021-325811↗
- Paper Pancreatic Cancer Cells Require the Transcription Factor MYRF to Maintain ER Homeostasis. DOI 10.1016/j.devcel.2020.09.011↗
- Paper FOXA2 controls the cis-regulatory networks of pancreatic cancer cells in a differentiation grade-specific manner. DOI 10.15252/embj.2019102161↗
- Andrea Viale · 1 shared paper, 2024 · strength 0.16
- Francesca Citron · 1 shared paper, 2024 · strength 0.16
- Alice Cortesi · 1 shared paper, 2024 · strength 0.16
- I-Lin Ho · 1 shared paper, 2024 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.